Skip to main content
I

ISD

ISD provides an AI‑powered platform that automates data analysis, trial optimization, and patient recruitment for clinical research organizations in Saudi Arabia, complemented by biostatistical consulting and secure cloud handling of health data. The company also offers customized training programs to build local expertise in AI, biostatistics, and clinical trial management, helping clients accelerate studies and improve drug development outcomes.

KAUST, Saudi ArabiaFounded 20242500+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Clinical research organizations in Saudi Arabia often face lengthy trial timelines, inefficient data analysis, and a shortage of skilled professionals equipped with modern AI tools, which hampers the speed and quality of biomedical discoveries.

Solution

ISD delivers AI‑enhanced services that automate and accelerate key aspects of clinical research, including data analytics, trial optimization, and patient recruitment. Their platform combines machine‑learning algorithms with expert biostatistical consulting to produce faster, more reliable insights while maintaining ethical standards. In addition, ISD offers tailored training programs that develop a sustainable talent pool for the Saudi biotech and healthcare sectors, ensuring organizations have access to qualified personnel. By integrating AI with human expertise, ISD reduces study durations, improves outcome predictability, and supports personalized drug development initiatives.

Target Audience

Primary customers are clinical research organizations, pharmaceutical companies, and academic biomedical institutes operating in Saudi Arabia that require accelerated trial execution and skilled workforce development.

Features

  • AI‑driven data analysis pipelines that clean, integrate, and model clinical datasets with minimal manual effort
  • Automated trial optimization tools that suggest protocol adjustments, site selection, and patient recruitment strategies
  • Expert biostatistical consulting services for study design, statistical planning, and regulatory compliance
  • Customized training curricula covering AI applications, biostatistics, and clinical trial management for Saudi professionals
  • Support for personalized drug development workflows, including biomarker identification and genomics data integration
  • Cloud‑based platform that ensures secure, compliant handling of sensitive health data
This profile is AI-generated and may contain inaccuracies.